Let's be honest, we're all drama queens sometimes. Whether you're texting your bestie you're “literally dying” over the latest celebrity gossip or declaring on social media that Monday mornings are ...

Your browser does not support the audio element. This story will praise and/or roast a product, company, service, game, or anything else people like to review on the ...

In his decades-long career in tech journalism, Dennis has written about nearly every type of hardware and software. He was a founding editor of Ziff Davis’ Computer Select in the 1990s, senior ...

J2EE-Example-Project/ ├── auth/ │ └── src/main/java/lk.jiat.app.ejb.bean/ │ └── UserSessionBean.java ├── core/ │ └── src/main/java ...

Orum Therapeutics Inc. on April 26 pulled the plug on a U.S.-based phase I study of ORM-5029, its lead oncology degrader antibody conjugate (DAC) asset, a decision that came months after the company ...

Hibernate ORM is a powerful object/relational mapping solution for Java, and makes it easy to develop persistence logic for applications, libraries, and frameworks. Hibernate implements JPA, the ...

Government regulation is getting a lot of attention these days. During the recent presidential election, both sides laid out competing visions for the role of government. And all 50 states have also ...

If you’re completely new to Microsoft Word, you’re probably wondering where to begin. You’ve come to the right place because we’ll get you started. From what you see in the Word window to how to save ...

Jockey Cory Orm faces a “long recovery” after a spill on Tuesday at FanDuel Sportsbook and Horse Racing, formerly Fairmount Park, in Collinsville, Ill. Agent Julie Mullins reports that Orm suffered an ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Dany Lepage discusses the architectural ...

Phase I study of adoptive T cell therapy following HER2-pulsed dendritic cell vaccine and pepinemab/trastuzumab in patients with metastatic HER2-positive breast cancer (MBC). This is an ASCO Meeting ...